Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for conditions leading to bone loss

Combination therapy for conditions leading to bone loss

US Patent 7005413 · Granted Feb 28, 2006

Estimated economic value: $571,400,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating tissue fibrosis with interleukin 242025
Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses there2023
Combination therapy using an IL-20 antagonist and an immune checkpoint inhibitor2023
Calcitonin gene-related peptide (CGRP) antagonist antibodies2023
Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1)2022
Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CT2022
Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the2022
Use of IL-20 antagonists for treating eye diseases2022
Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)2022
Anti-OX40 antibodies and methods of activating OX402022
Methods and compositions for treating tumor diseases2021
Compositions and methods relating to anti-IGF-1 receptor antibodies2018